Trial intelligence / Profile preview

Effect of Ciclesonide vs Fluticasone Propionate vs Placebo on Short-term Growth and HPA-axis Function in Prepubertal Children with Mild Asthma

2005-001386-34Phase 3Completed

Sponsor
Altana Pharma
Start
Jul 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in asthma comparing Ciclesonide arm, Fluticasone propionate arm and Placebo arm (3 arms). Primary endpoints: Short-term linear growth rate and HPA-axis function. Started Jul 2008; status: completed.

02

Drugs

ciclesonideFlixocort
03

Conditions

asthma

Beyond the preview

Go deeper on 2005-001386-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001386-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call